ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 163

Fluorescence Optical Imaging Reveals Distinct Patterns of Hand Joint Inflammation in Seropositive and Seronegative Early Rheumatoid Arthritis

Yogan Kisten1, Erik af Klint2, Hamed Rezaei2,3, Adrian Levitsky4, Per T Larsson2, Anna Karlsson2,3, Noémi Györi1, Ronald F. van Vollenhoven1,5 and Laurent Arnaud3, 1Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 2Medicine, Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 3Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 4Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 5Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoantibodies, Early Rheumatoid Arthritis, imaging techniques, inflammation and management

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Detection of abnormal Rheumatoid Arthritis (RA) related autoantibodies, Rheumatoid Factor (RF) and Anti- Citrullinated Peptide Antibody (ACPA), along with musculoskeletal ultrasound (MSUS) plays a critical role in early RA (eRA) diagnosis. Fluorescence optical imaging (FOI) is an emerging modality that detects subclinical hand joint inflammation1, and may therefore prove valuable in early RA assessment. Here, we analyzed the FOI results of eRA patients to determine whether patterns of hand joint inflammation were able to distinguish seropositive from seronegative eRA.

Methods: Inflammation on FOI is defined by altered microcirculation (capillary leakage/perfusion), which is seen as abnormal optical signal intensities during visual inspection of a 360-second series of hand and wrist joint images (34 joints per patient). Unsupervised ascending hierarchical clustering was used to identify clusters of patients with different patterns of joint involvement in FOI. The robustness of clustering was verified using k-means, and agreements between the 2 methods were assessed using Cohen’s kappa. Baseline clinical and biological characteristics of patients were compared between the clusters using non-parametric tests.

Results: Out of 1326 joints of 39 eRA patients (26 females; 9 with erosive RA; 54% RF+; and 69% ACPA+), 400 (30%) were considered positively inflamed by FOI. The mean (±SD) number of active joints detected by FOI was 10.3 ± 7.2 (Table).  Unsupervised hierarchical clustering of joint involvement according to FOI distinguished 2 separate clusters of patients: Cluster1 (n=29) & Cluster2 (n=10). The proportion of seropositive patients was significantly higher in cluster 1 versus cluster 2 (26/29 versus 3/10, p<0.01) (Figure). The distribution of inflammation throughout the joints, except for right MCP2, PIPs 5, left MCP1 & DIPs in cluster 2 displayed distinguishable patterns (p<0.05) compared to cluster 1, which showed joint inflammation to be largely concentrated around wrists, right MCP2, bilateral MCP3, and to a lesser degree around PIPs 2-4 & left MCP2. The DIPs showed no significant differences between clusters.

Conclusion: Unsupervised hierarchical clustering revealed two distinct inflammatory patterns of joint involvement that may be distinguished in early RA, using fluorescence optical imaging. The proportions of seropositive patients were significantly different between these patterns, suggesting that FOI identifies patterns of joint involvement that are different for seropositive and seronegative RA. References: 1. Kisten Y, Györi N, af Klint E, et al. 2015 Detection of clinically manifest and silent synovitis in the hands and wrists by fluorescence optical imaging. RMD Open 2015;1: e000106. doi:10.1136/ rmdopen-2015-000106 (http://rmdopen.bmj.com/content/1/1/e000106.full.pdf+html)

 


Disclosure: Y. Kisten, None; E. af Klint, None; H. Rezaei, None; A. Levitsky, None; P. T. Larsson, None; A. Karlsson, None; N. Györi, None; R. F. van Vollenhoven, •AbbVie, Amgen, BMS, GSK, Pfizer, Roche, UCB, 2,AbbVie, Biotest, BMS, Celgene, Crescendo, GSK, Janssen, Lilly, Merck, Novartis, Pfizer, Roche, UCB, Vertex, 5; L. Arnaud, None.

To cite this abstract in AMA style:

Kisten Y, af Klint E, Rezaei H, Levitsky A, Larsson PT, Karlsson A, Györi N, van Vollenhoven RF, Arnaud L. Fluorescence Optical Imaging Reveals Distinct Patterns of Hand Joint Inflammation in Seropositive and Seronegative Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/fluorescence-optical-imaging-reveals-distinct-patterns-of-hand-joint-inflammation-in-seropositive-and-seronegative-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fluorescence-optical-imaging-reveals-distinct-patterns-of-hand-joint-inflammation-in-seropositive-and-seronegative-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology